Sign in

CIK 0001933414

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Mineralys Therapeutics, Inc.

Sign in to watch
Ticker
MLYS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
841966887
Phone
+1 888-378-6240
Business address
150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,403,032
in 5 filings, $2.4M under 10b5-1 plans

Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-02-12 Rodman David Malcom Chief Medical Officer Option exercise +5,017 $0.54 $3K 37,917
2024-02-12 Rodman David Malcom Chief Medical Officer Option exercise +6,349 $1.08 $7K 44,266
2024-02-12 Rodman David Malcom Chief Medical Officer Option exercise · Stock Option −5,017 55,190
2024-02-12 Rodman David Malcom Chief Medical Officer Option exercise · Stock Option −6,349 215,851
2024-01-12 Rodman David Malcom Chief Medical Officer Option exercise +6,348 $1.08 $7K 32,900
2024-01-12 Rodman David Malcom Chief Medical Officer Option exercise · Stock Option −6,348 222,200
2024-01-11 Rodman David Malcom Chief Medical Officer Option exercise +5,017 $0.54 $3K 26,552
2024-01-11 Rodman David Malcom Chief Medical Officer Option exercise · Stock Option −5,017 60,207
2023-12-11 Rodman David Malcom Chief Medical Officer Option exercise +5,018 $0.54 $3K 20,069
2023-12-11 Rodman David Malcom Chief Medical Officer Option exercise · Stock Option −5,018 65,224
2023-11-22 Congleton Jon Chief Executive Officer Purchase +4,250 $5.97 $25K 1,049,068
2023-11-13 Rodman David Malcom Chief Medical Officer Option exercise +5,017 $0.54 $3K 15,051
2023-11-13 Rodman David Malcom Chief Medical Officer Option exercise · Stock Option −5,017 70,242
2023-11-03 Rodman David Malcom Chief Medical Officer Option exercise +10,034 $0.54 $5K 10,034
2023-11-03 Rodman David Malcom Chief Medical Officer Option exercise · Stock Option −10,034 75,259
2023-09-13 Karydas Daphne Director Grant or award · Stock Option +44,000 44,000
2023-09-13 SBLENDORIO GLENN Director Grant or award · Stock Option +44,000 44,000
2023-09-06 Congleton Jon Chief Executive Officer Purchase +2,250 $12.08 $27K 1,044,818
2023-08-17 Congleton Jon Chief Executive Officer Purchase +2,250 $12.10 $27K 1,042,568
2023-08-11 Rodman David Malcom Chief Medical Officer Option exercise +80,909 $0.54 $44K 80,909

Page 20 of 23 · 446 trades